Resumen

CUERVO-MALDONADO, Sonia Isabel et al. Fusariosis in cancer patients: 13 case series report and literature review. Biomed. [online]. 2023, vol.43, suppl.1, pp.41-56.  Epub 31-Ago-2023. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6925.

The fusariosis is an opportunistic mycosis caused by Fusarium spp. Its clinical presentation depends on the immunological status of the host, especially in patients with hemato-oncological diseases, whose manifestations vary from localized to invasive fungal infections. Skin or blood culture helps to guide combined antifungal treatment with amphotericin B and voriconazole.

Here, we present 13 cases in a period of eleven years of patients with cancer who developed disseminated fusariosis and their outcomes, together with a review of the related literature. In this series of cases, mortality was 61.5 % (8/13), despite the use of the antifungal. Out of the 13 cases, 11 had hematological neoplasia and 2 solid neoplasia. The most determinant risk factor was profound neutropenia. Skin involvement and positive blood cultures in most cases allowed combined treatment prescription. Persistent febrile neutropenia associated with skin lesions, onychomycosis, nodules, or lung masses lead to suspicion of Fusarium spp. fungal invasive infection.

The aim of this series of cases is to remind healthcare professionals that oncological patients with deep and persistent febrile neutropenia can develop fusariosis.

Palabras clave : Fusarium; fungemia; amphotericin B; voriconazole; spectrometry, mass, matrix-assisted laser desorption-ionization.

        · resumen en Español     · texto en Español     · Español ( pdf )